Login to Your Account

Constipation Phase III Positive

Ironwood, Forest 'Rooting' for Added Success In IBS

By Catherine Hollingsworth

Wednesday, November 4, 2009
Ironwood Pharmaceuticals Inc. and partner Forest Laboratories Inc. reported positive results from two pivotal Phase III trials of its bowel drug candidate linaclotide in chronic constipation. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription